Syngene International Limited (SYNGENE)
Outcome of Board Meeting
Q1FY27 results (unaudited):
Standalone:
Revenue 8.7bn -16% y-y (10.4bn)
PAT 0.9bn -41% y-y (1.5bn)
Consolidated:
Revenue 8.0bn -17% y-y (9.6bn)
PAT 0.7bn -50% y-y (1.5bn)
FY26 results (audited):
Standalone:
Revenue 38.1bn +2% y-y (37.4bn)
EBITDA 8.5bn +5% y-y (8.1bn)
EBITDA margin 22.3% (21.9%) +40 bps y-y
PAT 3.2bn +7% y-y (3.0bn)
Consolidated:
Revenue 34.9bn +2% y-y (34.2bn)
EBITDA 7.6bn +5% y-y (7.3bn)
EBITDA margin 21.7% (21.4%) +30 bps y-y
PAT 3.0bn +7% y-y (2.8bn)
Dividend: Rs 1.25/share (recommended, subject to AGM approval)
Commentary: Exceptional items include termination benefits and labour code impacts; subsidiary Syngene Manufacturing Solutions Limited is in voluntary liquidation.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 SYNGENE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add SYNGENE to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Syngene International Limited
Important.
The summary above is generated automatically from Syngene International Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.